2015 marked the second year since the establishment of the Ferrier Research Institute. The year was characterised by successes on many fronts, as our scientists continue our work on developing better drugs, industrial materials and manufacturing technologies.
Three different projects focused on solving a variety of problems, which are being led by scientists at the Ferrier Research Institute, have been awarded a total of $3 million in Government funding to develop their commercial potential.
Ferrier Research Institute scientists have developed what could possibly be an effective treatment against a common bacteria that causes stomach ulcers.
A new drug developed to treat a debilitating rare muscle-wasting disease and various kidney diseases, and manufactured using Ferrier Research Institute technology, has been acquired by an American company for commercial development.
An immunotherapy technology for treating cancer and other diseases, jointly developed by the Ferrier Research Institute and the Malaghan Institute of Medical Research, has been patented and will be the initial focus of a newly-formed company.
Chemists from the Ferrier Research Institute have helped to develop a new sustainable-based paint.
Ferrier Research Institute researchers have made a significant step forward in the search for a treatment for Alzheimer's disease.
